Marie Karanian - Concepedia

Author

Marie Karanian

Also Known As

Karanian, Marie, M. Karanian, M. Karanian-Philippe, M. Karanian‐Philippe, Marie Karanian, Marie Karanian-Philippe, Marie Karanian‐Philippe

134

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Centre Léon Bérard Inserm Université Claude Bernard Lyon 1 Institut Bergonié Centre de Recherche en Cancérologie de Lyon

About

Marie Karanian is an author at Centre Léon Bérard specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.1K
2	Cell Biology	5	5	480
3	Health Sciences	4	4	113
4	Engineering	1	1	18
5	Gastroenterology	1	1	18

Marie Karanian

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Transcriptomic definition of molecular subgroups of small round cell sarcomas Sarah Watson, Virginie Perrin, Delphine Guillemot, The Journal of Pathology Tumoral PathologyMalignant DiseaseTumor HeterogeneitySystematic SearchMedicine	2018	319
Surgery in reference centers improves survival of sarcoma patients: a nationwide study Jean‐Yves Blay, Charles Honoré, Eberhard Stoeckle, Annals of Oncology	2019	307
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network Gonzague de Pinieux, Marie Karanian, François Le Loarer, PLoS ONE	2021	252
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression Rémy Nicolle, Mira Ayadi, Anne Gomez‐Brouchet, Nature Communications	2019	96
SMARCA4 (BRG1) Loss of Expression Is a Useful Marker for the Diagnosis of Ovarian Small Cell Carcinoma of the Hypercalcemic Type (Ovarian Rhabdoid Tumor) Marie Karanian, Valérie Velasco, Michel Longy, The American Journal of Surgical Pathology Ovarian Rhabdoid TumorPathologyCancer BiologyTumor BiologyCarcinoma	2015	90
Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum François Le Loarer, Sophie Laffont, Tom Lesluyes, The American Journal of Surgical Pathology	2019	86
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial Javier Martín‐Broto, Josefina Cruz, Nicolas Penel, The Lancet Oncology Surgical OncologyMedicineSystemic TreatmentTheranosticsPathology	2020	84
Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans Marie Karanian, Gaëlle Pérot, Jean‐Michel Coindre, Modern Pathology Dermatofibrosarcoma ProtuberansHelpful TestSitu Hybridization AnalysisHistopathologyPathology	2014	83
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial Silvia Stacchiotti, Stefano Ferrari, Andrés Redondo, The Lancet Oncology MedicineOrthopaedic SurgerySurgery	2019	79
Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions Bérengère Dadone‐Montaudié, Laurent Alberti, Adeline Duc, Modern Pathology PathologyAlternative Pdgfd RearrangementsDermatologyDermatopathologyMatrix Biology	2018	76

Page 1